Cardiac Implantable Electronic Device Implantation With and Without Pectoral Nerve Block

Sponsor
Changi General Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT03061292
Collaborator
(none)
120
1
2
51.3
2.3

Study Details

Study Description

Brief Summary

Implantation of cardiac implantable electronic devices are generally carried out using intermittent intravenous conscious sedation combined with local anaesthesia. The main advantage of this technique is in avoiding the potential risks of general anaesthesia. However, the use of this Sedation - Local Anaesthesia technique is not without complications. Peri -procedural hypoxaemia and hypotension are well recognised complications of this technique.

The pectoral nerves (Pecs) blocks are novel techniques to block the pectoral, intercostobrachial, third to sixth intercostals, and the long thoracic nerves. PECS block targets the lateral and median pectoral nerves at an interfascial plane between the pectoralis major and minor muscles.

A case report by Fujiwara et al has described the use of this technique to provide good analgesia during and after these implantation procedures surgery. Pectoral nerves block along with minimal sedation has been used as a safe technique in our local set up as well.

Hence, we propose a randomized, single center, controlled trial on patients undergoing cardiac implantable electronic device implantation with local anaesthesia and sedation with and without Pectoral Nerve Block.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pectoral Nerve Block
  • Procedure: Without Pectoral Nerve Block
N/A

Detailed Description

Intervention group:

Pectoral nerve block will be performed by anaesthetist (not blinded) in cardiac catheterization laboratory using ultrasound guidance and strict aseptic technique.

Control group:

A sham "block" will be performed by anaesthetist in cardiac catheterization laboratory using strict aseptic technique.

Patients of both groups will be monitored by the Cardiologist ( performing the procedure) and the Nurse from the monitoring room.

A minimum period of 15 minutes will be allowed following the block, prior to device implantation procedure by cardiologist.

Numeric rating scale (NRS) will be used for assessment of pain. The assessment will be carried out at every 15 minutes from the start of the procedure till the end of the procedure (0, 15, 30, 45, 60 minutes etc) and also at specific time points. Numerical rating scale will also be assessed when the patient experiences pain at any point and in the recovery room (0, 15, 30 and if needed, 45, 60 minutes).

Further post-operative pain scores will be collected at 4 hours and 8 hours post-procedure.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Primary Purpose:
Other
Official Title:
A Randomized, Controlled Trial on Patients Undergoing Cardiac Implantable Electronic Device Implantation With Local Anaesthesia and Sedation With and Without Pectoral Nerve Block
Actual Study Start Date :
Jul 25, 2016
Anticipated Primary Completion Date :
Nov 1, 2020
Anticipated Study Completion Date :
Nov 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pectoral Nerve Block

Patients undergoing cardiac implantable electronic device implantation with local anaesthesia and sedation with pectoral nerve block

Procedure: Pectoral Nerve Block

Sham Comparator: Without Pectoral Nerve Block

Patients undergoing cardiac implantable electronic device implantation with local anaesthesia and sedation without pectoral nerve block

Procedure: Without Pectoral Nerve Block

Outcome Measures

Primary Outcome Measures

  1. Total dose of sedation used [2 years]

  2. Incidence of hypoxia, hypotension and hypopnea in the perioperative period [2 years]

  3. Perioperative sedation scores [2 years]

  4. Perioperative pain scores [2 years]

  5. Post-anaesthetic discharge score [2 years]

Secondary Outcome Measures

  1. Procedurist satisfaction scores [2 years]

  2. Patient satisfaction scores [2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Fulfilled the indication for CIED implantation as defined in 2008 guidelines for device-based therapy of cardiac rhythm abnormalities
Exclusion Criteria:
  • Pregnant

  • Those who receives subcutaneous implantable cardioverter defibrillator

  • Vulnerable subjects (children, prisoners, cognitive impaired persons)

  • Known history of allergy to local anaesthetic medications

Contacts and Locations

Locations

Site City State Country Postal Code
1 Changi General Hospital Singapore Singapore 529889

Sponsors and Collaborators

  • Changi General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Changi General Hospital
ClinicalTrials.gov Identifier:
NCT03061292
Other Study ID Numbers:
  • PECS
First Posted:
Feb 23, 2017
Last Update Posted:
Oct 8, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Oct 8, 2020